-transparent.png){kind=logo}
A novel series of nonpeptidic compounds that contain a biphenyl carboxylic acid group have been shown to inhibit HIV-1 protease. The active compounds, most of which are highly soluble, have IC50 values in the range of 3.4-74 microM. The structure-inhibitory activity relationship demonstrates the necessity of the biphenyl carboxylic acid group for inhibition, which is enhanced by the presence of a sulfone group and by halogenation of an adjacent phenyl group. A double reciprocal plot of inhibition data on two of the compounds clearly shows that the inhibition occurs in a competitive manner, with Ki values of 1.1 and 3.4 microM. Inhibition by several of the compounds was found to be reversible and fast-binding, while one of the biphenyl carboxylic acids inhibits in a reversible slow-binding manner. Time-dependent inhibition studies were conducted on this compound, and it was determined to have the kinetic values of kon = 0.18 microM-1min-1, koff = 9.7 x 10(-2)min-1, and Ki = 0.14 microM. Thus, the slow-binding inhibitor is the most potent in the series. Molecular modeling has provided information on a possible binding mode for two different biphenyl carboxylic acid inhibitors of HIV-1 protease.
P J Tummino, and
D Ferguson, and
C M Jacobs, and
B Tait, and
L Hupe, and
E Lunney, and
D Hupe
November 1970,
Bulletin of the Chemical Society of Japan,
P J Tummino, and
D Ferguson, and
C M Jacobs, and
B Tait, and
L Hupe, and
E Lunney, and
D Hupe
January 1997,
Biochemical and biophysical research communications,
P J Tummino, and
D Ferguson, and
C M Jacobs, and
B Tait, and
L Hupe, and
E Lunney, and
D Hupe
April 2008,
Chemical biology & drug design,
P J Tummino, and
D Ferguson, and
C M Jacobs, and
B Tait, and
L Hupe, and
E Lunney, and
D Hupe
September 2013,
Frontiers in microbiology,
P J Tummino, and
D Ferguson, and
C M Jacobs, and
B Tait, and
L Hupe, and
E Lunney, and
D Hupe
July 1993,
Biochemical and biophysical research communications,
P J Tummino, and
D Ferguson, and
C M Jacobs, and
B Tait, and
L Hupe, and
E Lunney, and
D Hupe
January 2020,
Evidence-based complementary and alternative medicine : eCAM,
P J Tummino, and
D Ferguson, and
C M Jacobs, and
B Tait, and
L Hupe, and
E Lunney, and
D Hupe
September 1992,
Journal of medicinal chemistry,
P J Tummino, and
D Ferguson, and
C M Jacobs, and
B Tait, and
L Hupe, and
E Lunney, and
D Hupe
January 1991,
Advances in experimental medicine and biology,
P J Tummino, and
D Ferguson, and
C M Jacobs, and
B Tait, and
L Hupe, and
E Lunney, and
D Hupe
January 1991,
Drug metabolism and disposition: the biological fate of chemicals,
P J Tummino, and
D Ferguson, and
C M Jacobs, and
B Tait, and
L Hupe, and
E Lunney, and
D Hupe
July 2014,
Journal of medicinal chemistry,
